La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Korean Drug Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Hai Park
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | no data |
| Proprietà del CEO | 11.4% |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | Nessun dato |
Aggiornamenti recenti sulla gestione
Recent updates
Unpleasant Surprises Could Be In Store For Korean Drug Co., Ltd.'s (KOSDAQ:014570) Shares
Jun 19
Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?
Mar 11Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?
Feb 19
Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?
Jan 11Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?
Dec 24Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today
Dec 06Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 18AMMINISTRATORE DELEGATO
Hai Park (89 yo)
no data
Mandato
Mr. Hai Ryong Park serves as Chairman, Chief Executive Officer and President of Korean Drug Co. Ltd. Mr. Park served as the Co-Chief Executive Officer of Korean Drug Co. Ltd., and also served as its Presid...